CiNPT for Abdominoplasties in Post-bariatric Patients Study (CAPS)
Primary Purpose
Obesity, Morbid, Obesity, Obesity, Abdominal
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
ciNPT group
Control group
Sponsored by
About this trial
This is an interventional prevention trial for Obesity, Morbid focused on measuring Closed-incision negative pressure therapy, Negative pressure wound therapy, Wound care, Surgical incision, Wound complication, Dehiscence, Surgical Site Infection, Seroma, Hematoma, Wound Healing, Inflammation, Incisional Wound, Abdominoplasty, Abdominal panniculectomy, Body contouring
Eligibility Criteria
Inclusion Criteria:
- previous bariatric surgery for weight loss
- candidate for/undergoing an abdominal panniculectomy (abdominoplasty)
- Residual BMI >30 kg/m2 at the time of the operation
- Evidence of pannus (abdominal) ptosis (Pittsburgh Rating Scale >2)
- Lipodystrophy and inelasticity of the skin
- Presence at the time of surgery of at least one local risk factor (e.g. a history or the presence of local complications such as skin blistering, recurrent erythema, panniculitis, or chronic infection; history of abdominal hernia or need for abdominal hernia repair) OR one systemic risk factor (diabetes, smoking habit, serum proteins below 6g/dL).
Exclusion Criteria:
- Severe systemic co-morbidities (defined as ASA III or higher)
- Malignant tumors
- Conditions or medications affecting wound healing (e.g. steroidal drugs or keloids)
- Known allergies to components of the treatment
- Presence of severe local cutaneous complications (open wounds, extensive infections) at the time of surgery.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Sham Comparator
Arm Label
ciNPT group
Control group
Arm Description
Subjects will receive post-operative incisional wound care by ciNPT (125 mmHg, continuous suction) for the first 7 days after surgery.
Subjects will receive post-operative incisional wound care by standard non-adherent surgical dressing (vaseline petrolatum gauze),
Outcomes
Primary Outcome Measures
Rate of post-surgical local complications
The change in post-surgical local complications (Skin blistering/necrosis, Surgical Site Infections, hematoma, seroma, need for re-operation) through 30 days after surgery.
Secondary Outcome Measures
Time-to-heal
A change in time (days) to complete wound closure for treated groups vs. controls.
Scar quality: Vancouver Scar Scale
A change in the macroscopic quality of scars at a 30 and 90 days follow up (measured with the Vancouver Scar Scale-VSS [Score range: 0-13, lower scores being a better outcome]).
Medical costs
A change in direct medical costs (considering cumulative costs related to: hospitalization, standard and additional post-operative care, additional surgical and medical care for complications) in the first 60 days after surgery.
Full Information
NCT ID
NCT04214236
First Posted
December 20, 2019
Last Updated
December 30, 2019
Sponsor
Azienda Ospedaliera, Ospedale Civile di Legnano
Collaborators
Acelity
1. Study Identification
Unique Protocol Identification Number
NCT04214236
Brief Title
CiNPT for Abdominoplasties in Post-bariatric Patients Study
Acronym
CAPS
Official Title
Evaluation of ciNPT Effects on Healing and Post-surgical Complications in High-risk Post- Bariatric Patients Undergoing Body-contouring Abdominoplasty: a Monocentric Prospective RCT
Study Type
Interventional
2. Study Status
Record Verification Date
December 2019
Overall Recruitment Status
Unknown status
Study Start Date
February 1, 2020 (Anticipated)
Primary Completion Date
November 1, 2022 (Anticipated)
Study Completion Date
January 31, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Azienda Ospedaliera, Ospedale Civile di Legnano
Collaborators
Acelity
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
The overarching goal of this research is to assess whether the post-operative use of closed-incision Negative Pressure Therapy (ciNPT) accelerates healing of surgical wounds, improves surgical outcomes, and reduces the rate of local complications in high-risk, obese, post-bariatric patients undergoing abdominal body-contouring procedures (abdominal panniculectomy or "abdominoplasty") compared to standard wound care.
The investigators postulate that ciNPT can cost-effectively improve outcomes and standard of post-surgical care in this specific category of patients.
This hypothesis will be tested through a prospective, interventional, case-control, randomized clinical trial.
Detailed Description
In the United States (US) 37% of the adult population is obese and 5% is considered morbidly obese. Similar trends have been observed in Europe and more recently in Asia. A large number of obese patients seeks treatment through bariatric surgery or diet-lifestyle changes. The resulting massive loss of weight leaves patients with an excess cutaneous tissue, requiring body-contouring procedures.
In the US 85% of post-bariatric patients seek body-contouring surgeries. Due to systemic and local factors, these procedures show a rate of local complications as high as 68-80%, significantly prolonging hospitalization and increasing treatment-related costs.
Several clinical studies have shown that external suction (Closed Incision Negative-Pressure Therapy, ciNPT) can accelerate closure of surgical wounds in patients at high-risk for impaired/delayed healing and can significantly reduce the rate of local complications. The investigators believe that ciNPT might significantly decrease the rate of minor local complications in post-bariatric patients undergoing body-contouring procedures, and that this strategy could represent a cost-effective adjuvant treatment in body-contouring procedures.
The investigators' preliminary study experience on post-bariatric obese patients undergoing an abdominoplasty and post-operatively treated with ciNPT, showed that ciNPT promotes effective and prompt wound closure minimizing peri-operative/post-operative complications in these patients. The investigators also showed that ciPNT positively impacts the length of hospitalization and the rate of secondary surgeries in these patients.
Based on this successful preliminary experience, the invetsigators here propose to validate these findings in a prospective RCT.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Morbid, Obesity, Obesity, Abdominal, Wound, Wound Infection, Wound Complication, Wound Dehiscence, Wound Contamination, Wound Heal, Wound; Abdomen, Incision, Incision Site Rash, Incision Site Bleeding, Incision Site Swelling, Incision Site Haematoma, Incision Site Infection, Incision Site Inflammation, Incision Site Complication, Incision Surgical, Surgery--Complications, Surgical Wound Infection, Surgical Site Infection, Scarring as Surgical Complication, Scar, Scarring
Keywords
Closed-incision negative pressure therapy, Negative pressure wound therapy, Wound care, Surgical incision, Wound complication, Dehiscence, Surgical Site Infection, Seroma, Hematoma, Wound Healing, Inflammation, Incisional Wound, Abdominoplasty, Abdominal panniculectomy, Body contouring
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Case-control Experimental/Interventional Group: post-operative ciNPT (first 7 days) Control Group: post-operative standard wound care
Masking
Outcomes Assessor
Masking Description
Analysis of data and statistical analysis will be blinded to groups.
Allocation
Randomized
Enrollment
130 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
ciNPT group
Arm Type
Experimental
Arm Description
Subjects will receive post-operative incisional wound care by ciNPT (125 mmHg, continuous suction) for the first 7 days after surgery.
Arm Title
Control group
Arm Type
Sham Comparator
Arm Description
Subjects will receive post-operative incisional wound care by standard non-adherent surgical dressing (vaseline petrolatum gauze),
Intervention Type
Device
Intervention Name(s)
ciNPT group
Other Intervention Name(s)
ciNPT, PREVENA™ Incision Management System, closed-incision negative pressure therapy
Intervention Description
Closed-incision negative pressure therapy (ciNPT) will be applied for 7 day using continuous suction at 125 mmHg. To deliver ciNPT we will use a commercially available, FDA-approved device, used according to the manufacturer' indications (PREVENA™ Incision Management System (KCI, San Antonio, Texas, USA). After the first 7 post-operative days, subjects will discontinue the ciNPT and follow a standard wound care protocol.
Intervention Type
Other
Intervention Name(s)
Control group
Other Intervention Name(s)
Standard incisional wound care
Intervention Description
Standard non-adherent surgical dressing (Vaseline petrolatum gauze) will be used for management of incisional wounds in the control group. Dressing changes will be performed per standard wound care protocol.
Primary Outcome Measure Information:
Title
Rate of post-surgical local complications
Description
The change in post-surgical local complications (Skin blistering/necrosis, Surgical Site Infections, hematoma, seroma, need for re-operation) through 30 days after surgery.
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Time-to-heal
Description
A change in time (days) to complete wound closure for treated groups vs. controls.
Time Frame
<60 days
Title
Scar quality: Vancouver Scar Scale
Description
A change in the macroscopic quality of scars at a 30 and 90 days follow up (measured with the Vancouver Scar Scale-VSS [Score range: 0-13, lower scores being a better outcome]).
Time Frame
30 and 90 days
Title
Medical costs
Description
A change in direct medical costs (considering cumulative costs related to: hospitalization, standard and additional post-operative care, additional surgical and medical care for complications) in the first 60 days after surgery.
Time Frame
60 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
previous bariatric surgery for weight loss
candidate for/undergoing an abdominal panniculectomy (abdominoplasty)
Residual BMI >30 kg/m2 at the time of the operation
Evidence of pannus (abdominal) ptosis (Pittsburgh Rating Scale >2)
Lipodystrophy and inelasticity of the skin
Presence at the time of surgery of at least one local risk factor (e.g. a history or the presence of local complications such as skin blistering, recurrent erythema, panniculitis, or chronic infection; history of abdominal hernia or need for abdominal hernia repair) OR one systemic risk factor (diabetes, smoking habit, serum proteins below 6g/dL).
Exclusion Criteria:
Severe systemic co-morbidities (defined as ASA III or higher)
Malignant tumors
Conditions or medications affecting wound healing (e.g. steroidal drugs or keloids)
Known allergies to components of the treatment
Presence of severe local cutaneous complications (open wounds, extensive infections) at the time of surgery.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Silvio Abatangelo, M.D.
Phone
+39 (02) 97 96 3466
Email
caps.trial@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Silvio Abatangelo, M.D.
Organizational Affiliation
ASST Ovest Milanese
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
IPD will not be shared.
Citations:
PubMed Identifier
29730777
Citation
Abatangelo S, Saporiti E, Giatsidis G. Closed Incision Negative-Pressure Therapy (ciNPT) Reduces Minor Local Complications in Post-bariatric Abdominoplasty Body Contouring: a Retrospective Case-Control Series. Obes Surg. 2018 Jul;28(7):2096-2104. doi: 10.1007/s11695-018-3279-8.
Results Reference
result
Learn more about this trial
CiNPT for Abdominoplasties in Post-bariatric Patients Study
We'll reach out to this number within 24 hrs